Results 311 to 320 of about 207,426 (323)

Complement Factor H Polymorphism and Age-Related Macular Degeneration

Science, 2005
A. Edwards, R. Ritter, K. Abel, A. Manning, Carolien I. M. Panhuysen, L. Farrer   +5 more
semanticscholar   +1 more source

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.

Ophthalmology (Rochester, Minn.), 2012
J. Heier, David M. Brown, V. Chong, J. Korobelnik, P. Kaiser, Q. Nguyen, B. Kirchhof, A. Ho, Y. Ogura, G. Yancopoulos, N. Stahl, R. Vitti, Alyson J. Berliner, Y. Soo, Majid Anderesi, G. Groetzbach, B. Sommerauer, R. Sandbrink, C. Simader, U. Schmidt-Erfurth   +19 more
semanticscholar   +1 more source

The role of oxidative stress in the pathogenesis of age-related macular degeneration.

Survey of ophthalmology, 2000
S. Beatty, H. Koh, M. Phil, D. Henson, M. Boulton   +4 more
semanticscholar   +1 more source

Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice

Nature Biomedical Engineering, 2021
Sikai Ling, Shiqi Yang, Xinde Hu, Di Yin, Yao Dai, Xiaoqin Qian, Dawei Wang, Xiaoyong Pan, Jiaxu Hong, Xiaodong Sun, Hui Yang, S. Paludan, Yujia Cai   +12 more
semanticscholar   +1 more source

Clinical classification of age-related macular degeneration.

Ophthalmology (Rochester, Minn.), 2013
F. Ferris, C. P. Wilkinson, A. Bird, U. Chakravarthy, E. Chew, K. Csaky, S. Sadda   +6 more
semanticscholar   +1 more source

Predicting conversion to wet age-related macular degeneration using deep learning

Nature Medicine, 2020
Jason Yim, Reena Chopra, Terry Spitz, Jim Winkens, A. Obika, Christopher J. Kelly, Harry Askham, M. Lukić, Josef Huemer, K. Fasler, Gabriella Moraes, Clemens Meyer, Marc Wilson, Jonathan Dixon, Cían O. Hughes, G. Rees, P. Khaw, A. Karthikesalingam, Dominic King, D. Hassabis, Mustafa Suleyman, T. Back, J. Ledsam, P. Keane, Jeffrey De Fauw   +24 more
semanticscholar   +1 more source

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.

Ophthalmology (Rochester, Minn.), 2009
David M. Brown, M. Michels, P. Kaiser, J. Heier, J. P. Sy, T. Ianchulev   +5 more
semanticscholar   +1 more source

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

The Lancet, 2015
S. Schwartz, C. Regillo, B. Lam, D. Eliott, P. Rosenfeld, N. Gregori, J. Hubschman, Janet L. Davis, Gad Heilwell, M. Spirn, J. Maguire, R. Gay, Jane Bateman, Rosaleen M Ostrick, Debra Morris, Matthew J. Vincent, E. Anglade, L. Priore, R. Lanza   +18 more
semanticscholar   +1 more source

Phase 1 clinical study of an embryonic stem cell–derived retinal pigment epithelium patch in age-related macular degeneration

Nature Biotechnology, 2018
L. da Cruz, K. Fynes, O. Georgiadis, Julie E Kerby, Y. Luo, A. Ahmado, A. Vernon, J. Daniels, B. Nommiste, S. Hasan, Sakina B. Gooljar, A. Carr, A. Vugler, Conor M. Ramsden, M. Bictash, Mike Fenster, Juliette Steer, Tricia Harbinson, Anna L. Wilbrey, A. Tufail, G. Feng, Mark Whitlock, A. Robson, G. Holder, M. Sagoo, P. Loudon, P. Whiting, P. Coffey   +27 more
semanticscholar   +1 more source

Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

A M A Archives of Ophthalmology, 1999

semanticscholar   +1 more source